Coronavirus vaccine in the works for COVID-19 by China’s CanSino Biologics. Photo: CanSino Biologics
Explainer |
Covid-19 vaccine, treatment hunt sends Chinese biopharmaceuticals soaring. What investors need to know
- Share prices of Chinese biotechs targeting Covid-19 have soared
- Covid-19 is an especially virulent type of virus that makes coming up with a vaccine even harder
Topic |
Coronavirus China
Coronavirus vaccine in the works for COVID-19 by China’s CanSino Biologics. Photo: CanSino Biologics
